Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Neoplasms of the CNS

Free Subscription 02.03.2026 1 AJNR Am J Neuroradiol 1 BMC Cancer 3 Br J Neurosurg 2 Childs Nerv Syst 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 9 J Neurooncol 1 J Neuropathol Exp Neurol 9 Neuro Oncol 1 Neurology 1 Neuroradiology 2 Neurosurgery 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. VU KV, Otis HG, Brandmaier A, Osborne JR, et al
   [68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker.
   AJNR Am J Neuroradiol. 2026 Feb 23:ajnr.A9260. doi: 10.3174/ajnr.A9260.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. LIU M, Zhao K, Yang C, Sun G, et al
   Detection of IDH1.R132H mutant protein in plasma extracellular vesicles and its application in preoperative noninvasive precision diagnosis of glioma.
   BMC Cancer. 2026 Feb 28. doi: 10.1186/s12885-026-15810.
   PubMed        
   
   

   
   Br J Neurosurg

3. FREUND BE, Barrios ML, Feyissa AM, Sabsevitz D, et al
   A review of acute symptomatic seizures during awake craniotomy for tumour resection.
   Br J Neurosurg. 2024 Oct 16:1-6. doi: 10.1080/02688697.2024.2410774.
   PubMed         Abstract available
   
   
4. CHEN CY, Chen JS, Chen YS, Yin CH, et al
   Identifying prognostic predictors for postoperative pituitary neuroendocrine tumour recurrence: an integrated clinical, radiological, and immunohistochemistry assessment.
   Br J Neurosurg. 2026;40:45-52.
   PubMed         Abstract available
   
   
5. CORAZZELLI G, Zanuttini L, Balestrini D, Quercia S, et al
   Strategic insights and survival outcomes: a systematic review of CNS metastases in uterine cervical cancer.
   Br J Neurosurg. 2024 Oct 23:1-14. doi: 10.1080/02688697.2024.2418490.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

6. CAVALHEIRO S, Pavon LF, de Farias CB, da Silva NS, et al
   Evaluating temozolomide for pediatric adamantinomatous craniopharyngiomas using microspheroid-based drug screening.
   Childs Nerv Syst. 2026;42:89.
   PubMed         Abstract available
   
   
7. YAMAKI VN, Sidpra J, Peres BS, Lind V, et al
   Long-term outcomes of paediatric craniopharyngiomas: a comparison of two large international series.
   Childs Nerv Syst. 2026;42:82.
   PubMed         Abstract available
   
   

   
   Int J Cancer

8. WELLER J, Katzendobler S, Thiele F, Riesberg A, et al
   Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancer.
   Int J Cancer. 2026 Feb 25. doi: 10.1002/ijc.70407.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

9. KOTECHA R, Chiang V, Tom MC, Parent E, et al
   (18)F-Fluciclovine for Detection of Recurrent Brain Metastases After Radiotherapy: Image Interpretation Criteria and Diagnostic Performance from the PURSUE Study.
   Int J Radiat Oncol Biol Phys. 2026 Feb 25:S0360-3016(26)00431.
   PubMed         Abstract available
   
   

   
   J Neurooncol

10. DUFFAU H
    Traveling large distances for awake functional-based surgery of IDH-mutated grade 2 glioma: outcomes comparison between loco-regional versus international patients.
    J Neurooncol. 2026;177:20.
    PubMed        
    
    
11. PICART T, Ducray F
    Comment on: "Extent of resection and adjuvant treatment in adult cerebellar glioblastoma: systematic review and meta-analysis of survival outcomes".
    J Neurooncol. 2026;177:21.
    PubMed        
    
    
12. ALHALABI OT, Mironov K, Nabiev K, Kramer J, et al
    Repeat resection for recurrent glioblastoma - does timing matter?
    J Neurooncol. 2026;177:14.
    PubMed         Abstract available
    
    
13. MENDOZA MIRELES EE, Blakstad H, Server A, Leske H, et al
    Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study.
    J Neurooncol. 2026;177:15.
    PubMed         Abstract available
    
    
14. ZHENG S, Lin L, Ren G, Lan H, et al
    Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma.
    J Neurooncol. 2026;177:16.
    PubMed         Abstract available
    
    
15. NATH B, Bobholz SA, Kim DC, Lowman AK, et al
    Altered perivascular diffusivity in glioblastoma: integrating DTI-ALPS index with radio-pathomic and histopathologic correlates.
    J Neurooncol. 2026;177:12.
    PubMed         Abstract available
    
    
16. RAUCH S, Wan Y, Halai A, Manly T, et al
    Multidimensional cognitive reserve and cognitive outcomes in glioblastoma: a pre- and postoperative analysis.
    J Neurooncol. 2026;177:11.
    PubMed         Abstract available
    
    
17. LEE JY, Koo JY, Kim NI, Kim SS, et al
    HER2 heterogeneity between primary cancers and brain metastases: a retrospective analysis of 185 matched pairs across multiple cancer types.
    J Neurooncol. 2026;177:10.
    PubMed        
    
    
18. MALHOTRA R, Moitra P, Chatterjee A, Kota PK, et al
    Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study.
    J Neurooncol. 2026;177:9.
    PubMed        
    
    

    
    J Neuropathol Exp Neurol

19. COTY-FATTAL Z, Smith H, McCord M, Mejia-Bautista M, et al
    Rapid assessment of MGMT promoter methylation status by droplet digital polymerase chain reaction on intraoperative smear preparation: A proof-of-concept study.
    J Neuropathol Exp Neurol. 2026;85:280-284.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

20. CASHMAN KS, Mistry AM, Kesarwani A, De Andrade Costa A, et al
    Oncolytic Zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses.
    Neuro Oncol. 2026 Feb 23:noag037. doi: 10.1093.
    PubMed         Abstract available
    
    
21. STOREVIK S, Augustsson MT, Moreino S, Koppe H, et al
    Mitochondria transfer in Glioblastoma.
    Neuro Oncol. 2026 Feb 23:noag038. doi: 10.1093.
    PubMed         Abstract available
    
    
22. YU M, Undergraduate CC, Gong Y, Md TT, et al
    Efficacy and Safety of Aumolertinib/Icotinib Combination Therapy for Naive EGFR-Mutant NSCLC Patients with Brain Metastases: A Phase I/II Study.
    Neuro Oncol. 2026 Feb 23:noag036. doi: 10.1093.
    PubMed         Abstract available
    
    
23. 
    Corrigendum to: The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas.
    Neuro Oncol. 2026 Feb 23:noaf291. doi: 10.1093.
    PubMed        
    
    
24. 
    Erratum to: Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
    Neuro Oncol. 2026 Feb 26:noag031. doi: 10.1093.
    PubMed        
    
    
25. ASAD M, Inocencio J, Mitrasinovic S, Aoki M, et al
    TIGIT expression dictates the immunosuppressive reprogramming of myeloid cells in glioblastoma.
    Neuro Oncol. 2026 Feb 25:noag044. doi: 10.1093.
    PubMed         Abstract available
    
    
26. TAYLOR JW
    Measuring what matters: Tumor volumes in IDH-mutant gliomas.
    Neuro Oncol. 2026 Feb 25:noag040. doi: 10.1093.
    PubMed        
    
    
27. GOMEZ-MAHIQUES M, Lopez-Mateu C, Gil-Terron FJ, Montosa-I-Mico V, et al
    Automated Delineation of Putative Non-Contrast-Enhancing Tumor in Glioblastoma: Prognostic Insights.
    Neuro Oncol. 2026 Feb 25:noag042. doi: 10.1093.
    PubMed         Abstract available
    
    
28. LI Y, Kang T, Jia Z, Lu C, et al
    NQO1-Mediated Oxidative Stress Resistance and Tumor Microenvironment Remodeling in Glioblastoma.
    Neuro Oncol. 2026 Jan 27:noag015. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurology

29. BASELGA-GARRIGA C, Purohit S, Lamba N, Catalano PJ, et al
    Primary Motor Cortex Involvement and Its Association With Seizure Risk in Patients With Brain Metastases.
    Neurology. 2026;106:e214714.
    PubMed         Abstract available
    
    

    
    Neuroradiology

30. HU C, Yang R, Yan Z, Shen M, et al
    Time-dependent diffusion MRI for differentiating non?small cell lung?cancer brain metastases from breast?cancer brain metastases and gliomas.
    Neuroradiology. 2026 Feb 25. doi: 10.1007/s00234-026-03949.
    PubMed        
    
    

    
    Neurosurgery

31. VOGLIS S, Stumpo V, Bellomo J, Staartjes VE, et al
    Letter: Impact of Extent of Resection on Survival in Brain Metastasis: An Analysis of 867 Patients.
    Neurosurgery. 2026 Feb 27. doi: 10.1227/neu.0000000000003968.
    PubMed        
    
    
32. HULSBERGEN AFC, Broekman MLD
    In Reply: Impact of Extent of Resection on Survival in Brain Metastasis: An Analysis of 867 Patients.
    Neurosurgery. 2026 Feb 27. doi: 10.1227/neu.0000000000003969.
    PubMed        
    
    

    
    PLoS One

33. LIU J, Zhang C, Xu J, Wang L, et al
    Hyperspectral imaging for intraoperative brain tumor identification through fusion of spectral, textural, and spectral index features.
    PLoS One. 2026;21:e0340879.
    PubMed         Abstract available
    
    
34. DEVADAS P, Mathivanan G
    Mask - Region-based Convolutional Neural Networks (R-CNN) with Radiomics Integration and Gray Level Co-occurrence Matrix (GLCM) for brain tumor detection and segmentation.
    PLoS One. 2026;21:e0342185.
    PubMed         Abstract available
    
    
35. 
    Expression of Concern: Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1.
    PLoS One. 2026;21:e0343458.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum